Help | RSS Feed



Illumina, Inc. (NASD:ILMN) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Illumina, Inc. (NASD:ILMN) seasonal charts above shows that a Buy Date of October 15 and a Sell Date of January 21 has resulted in a geometric average return of 10.21% above the benchmark rate of the S&P 500 Total Return Index over the past 19 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success, but the return underperforms the relative buy-and-hold performance of the stock over the past 19 years by an average of 5.3% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (about 70% of sales). Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (12% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 18% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.

To download ILMN seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore